Prevalence of auto-Abs against type I IFNs in the general population
| Type I IFN auto-Ab (in plasma 1/10) | Age | Proportion of individuals from the general population with neutralizing auto-Abs (%) |
|---|---|---|
| Anti-IFN-α2 (100 pg/ml) | Children <18 years | 0.2% |
| Adults <65 years | 0.3% | |
| Adults ≥65 years | 2.6% | |
| Anti-IFN-ω (100 pg/ml) | Children <18 years | 2% |
| Adults <65 years | 0.9% | |
| Adults ≥65 years | 2.2% |
| Type I IFN auto-Ab (in plasma 1/10) | Age | Proportion of individuals from the general population with neutralizing auto-Abs (%) |
|---|---|---|
| Anti-IFN-α2 (100 pg/ml) | Children <18 years | 0.2% |
| Adults <65 years | 0.3% | |
| Adults ≥65 years | 2.6% | |
| Anti-IFN-ω (100 pg/ml) | Children <18 years | 2% |
| Adults <65 years | 0.9% | |
| Adults ≥65 years | 2.2% |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.